These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Acute extrapyramidal syndrome and neuroleptical malignant syndrome. A case report]. Cesario V Recenti Prog Med; 2008 Mar; 99(3):146-8. PubMed ID: 18488526 [TBL] [Abstract][Full Text] [Related]
43. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal. Thomas A; Onofrj M Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099 [No Abstract] [Full Text] [Related]
44. Parkinsonism following neuroleptic withdrawal. Nelli AC; Yarden PE; Guazzelli M; Feinberg I Arch Gen Psychiatry; 1989 Apr; 46(4):383-4. PubMed ID: 2564765 [No Abstract] [Full Text] [Related]
45. Neuroleptic malignant syndrome: an experience of four cases. Desai ND; Mundra VK; Gore YS; Diwan PJ; Jaydeokar SS; Jain V; Sutharsan R; Agarwal A; Moulick ND; Manocha SM J Assoc Physicians India; 1998 Jul; 46(7):653-4. PubMed ID: 12152854 [TBL] [Abstract][Full Text] [Related]
46. Tardive Tourette syndrome in an autistic patient after long-term neuroleptic administration. Stahl SM Am J Psychiatry; 1980 Oct; 137(10):1267-9. PubMed ID: 6106393 [No Abstract] [Full Text] [Related]
47. Cholinergic syndrome from psychotropic withdrawal in a marijuana abuser. Dilsaver SC; Leckrone J; Greden JF Psychosomatics; 1984 Aug; 25(8):632-4. PubMed ID: 6332335 [No Abstract] [Full Text] [Related]
50. Withdrawal phenomena associated with antidepressant and antipsychotic agents. Dilsaver SC Drug Saf; 1994 Feb; 10(2):103-14. PubMed ID: 7912078 [TBL] [Abstract][Full Text] [Related]
51. Concurrent haloperidol withdrawal and benztropine overdose: a case report. West RR; Newgreen DB Compr Psychiatry; 1978; 19(6):557-60. PubMed ID: 720041 [No Abstract] [Full Text] [Related]
52. Sedation effects on responsiveness: evaluating the reduction of antipsychotic medication in people with intellectual disability using a conditional probability approach. Smith C; Felce D; Ahmed Z; Fraser WI; Kerr M; Kiernan C; Emerson E; Robertson J; Allen D; Baxter H; Thomas J J Intellect Disabil Res; 2002 Sep; 46(Pt 6):464-71. PubMed ID: 12354317 [TBL] [Abstract][Full Text] [Related]